Literature DB >> 11015299

Differential regulation of P2Y(11) receptor-mediated signalling to phospholipase C and adenylyl cyclase by protein kinase C in HL-60 promyelocytes.

B C Suh1, T D Kim, I S Lee, K T Kim.   

Abstract

The regulatory mode of the P2Y(11) purinoceptor-mediated signalling cascades towards phospholipase C and adenylyl cyclase was studied in HL-60 promyelocytes. Treatment with the potent P2Y(11) receptor activator dATP evoked an elevated intracellular Ca(2+) concentration ([Ca(2+)](i)) and inositol 1,4,5-trisphosphate (IP(3)) production that was sustained for longer than 30 min. However, the dATP-induced responses were significantly inhibited by the activation of protein kinase C after a short exposure to phorbol 12-myristate 13-acetate (PMA). dATP also potently stimulated cyclic AMP production with half maximum effect seen at 23+/-7 microM dATP. In addition, a 5-min pretreatment with PMA enhanced the dATP-stimulated cyclic AMP accumulation. PMA potentiated the cyclic AMP production when adenylyl cyclase was activated directly by forskolin or indirectly by G protein activation after cholera toxin treatment. dATP also enhanced the forskolin-mediated cyclic AMP generation. Treatment of the cells with 10 microM U-73122, which almost completely blocked the dATP-stimulated IP(3) production and [Ca(2+)](i) rise, had no effect on cyclic AMP accumulation, while 10 microM 9-(tetrahydro-2-furyl)adenine (SQ 22536), which inhibited the adenylyl cyclase activation, did not effect the dATP-stimulated phosphoinositide turnover. Taken together, the results indicate that P2Y(11) receptor-mediated activation of phospholipase C and adenylyl cyclase occurs through independent pathways and is differentially regulated by protein kinase C in HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015299      PMCID: PMC1572341          DOI: 10.1038/sj.bjp.0703581

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Differential activation of adenylyl cyclase by protein kinase C isoenzymes.

Authors:  J Kawabe; G Iwami; T Ebina; S Ohno; T Katada; Y Ueda; C J Homcy; Y Ishikawa
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

Review 2.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.

Authors:  R A Challiss; E R Chilvers; A L Willcocks; S R Nahorski
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

4.  Extracellular nucleotides stimulate receptor-mediated calcium mobilization and inositol phosphate production in human fibroblasts.

Authors:  J Fine; P Cole; J S Davidson
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

5.  Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells.

Authors:  P A Watson; J Krupinski; A M Kempinski; C D Frankenfield
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

6.  Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells.

Authors:  G F Wilkinson; J R Purkiss; M R Boarder
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

7.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.

Authors:  C E Parr; D M Sullivan; A M Paradiso; E R Lazarowski; L H Burch; J C Olsen; L Erb; G A Weisman; R C Boucher; J T Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

8.  Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2.

Authors:  O Jacobowitz; R Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Differential regulation of inositol 1,4,5-trisphosphate by co-existing P2Y-purinoceptors and nucleotide receptors on bovine aortic endothelial cells.

Authors:  J R Purkiss; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

10.  Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways.

Authors:  D Communi; E Raspe; S Pirotton; J M Boeynaems
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

View more
  6 in total

Review 1.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 2.  Regulation and organization of adenylyl cyclases and cAMP.

Authors:  Dermot M F Cooper
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

3.  Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase.

Authors:  A D Qi; C Kennedy; T K Harden; R A Nicholas
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 4.  A critical look at the function of the P2Y11 receptor.

Authors:  Karin Dreisig; Birgitte Rahbek Kornum
Journal:  Purinergic Signal       Date:  2016-05-31       Impact factor: 3.765

5.  Caspase-3 and -9 are activated in human myeloid HL-60 cells by calcium signal.

Authors:  D González; J Espino; I Bejarano; J J López; A B Rodríguez; J A Pariente
Journal:  Mol Cell Biochem       Date:  2009-07-21       Impact factor: 3.396

6.  Differentiation of hematopoietic stem cell and myeloid populations by ATP is modulated by cytokines.

Authors:  C M V Barbosa; C M M P Leon; A Nogueira-Pedro; F Wasinsk; R C Araújo; A Miranda; A T Ferreira; E J Paredes-Gamero
Journal:  Cell Death Dis       Date:  2011-06-02       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.